About
Therapeutic and diagnostic products for the early detection and treatment of cancer
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalAntibodyVirginia, DC, DE & Maryland
Team (11)
Adam S. Mostafa
Board MemberAdam S. MostafaBoard Member
Precision Biologics
team_member
Al Tsang
OfficerAl TsangChief Scientific Officer
Precision Biologics
team_member
Christina M. Annunziata
Board MemberChristina M. AnnunziataBoard Member
Precision Biologics
team_member
Christopher Hyun
Board MemberChristopher HyunBoard Member
Precision Biologics
team_member
Jim Feldman
Board MemberJim FeldmanBoard Member
Precision Biologics
team_member
Joyson Karakunnel
Board MemberJoyson KarakunnelBoard Member
Precision Biologics
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
396
By Phase
PHASE1/PHASE2: 3
By Status
UNKNOWN: 1RECRUITING: 1TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT04493307Collaborator
The Evaluation of Hemostasis in Hospitalized COVID-19 Patients
N/AUnknown
100 participants
Started: Jun 30, 2020 · Completed: Jun 30, 2021
NCT03476681Lead Sponsor
Study of NEO-201 in Solid Tumors Expansion Cohorts
PHASE1/PHASE2Recruiting
121 participants
Started: Jan 18, 2019 · Completed: Jan 15, 2029
NCT01834235Lead Sponsor
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
PHASE1/PHASE2Terminated
81 participants
Started: Apr 30, 2013 · Completed: Dec 31, 2019
NCT01040000Lead Sponsor
QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
PHASE1/PHASE2Completed
94 participants
Started: Jan 31, 2012 · Completed: Mar 31, 2017
Locations (1)
Headquarters
Bethesda, MD, United States
Map
Loading map...